Literature DB >> 22588321

Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy.

Murat Biteker1, Erkan Ilhan, Gul Biteker, Dursun Duman, Biykem Bozkurt.   

Abstract

AIMS: Persistence of left ventricular (LV) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (PPCM). We sought to determine the length of time required for recovery of LV systolic function (LVSF) in patients with PPCM. METHODS AND
RESULTS: Forty-two consecutive women with PPCM were enrolled in this prospective study. The minimum required time of follow-up for inclusion was 30 months. Each patient underwent transthoracic echocardiography, and plasma brain natriuretic peptide (BNP) and C-reactive protein measurement at admission, and every 3 months. Early recovery was defined as normalization of LVSF at 6 months post-diagnosis. Delayed recovery was defined if the length of time required for recovery of LVSF was longer than 6 months. Persistent left ventricular dysfunction (PLVD) was defined as an ejection fraction of <50% at the end of follow-up. Twenty patients (47.6%) recovered completely, 10 died (23.8%), and 12 (28.6%) had PLVD. Average time to complete recovery was 19.3 months after initial diagnosis (3-42 months). Early recovery was observed only in six patients (30%), whereas delayed recovery was observed in 14 out of 20 patients (70%). Patients with complete recovery were more likely to have a higher LV ejection fraction and smaller LV end-systolic dimensions at baseline.
CONCLUSION: Full recovery of LVSF in PPCM patients often requires longer than 6 months.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588321     DOI: 10.1093/eurjhf/hfs070

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  24 in total

Review 1.  Detection and management of arrhythmias in peripartum cardiomyopathy.

Authors:  Julian Hoevelmann; Lina Hähnle; Julia Hähnle; Karen Sliwa; Charle Viljoen
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 2.  Peripartum cardiomyopathy: Status 2018.

Authors:  Divya Gupta; Nanette K Wenger
Journal:  Clin Cardiol       Date:  2018-02-16       Impact factor: 2.882

3.  Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India.

Authors:  Aditya John Binu; Sudha Jasmine Rajan; Swati Rathore; Manisha Beck; Annie Regi; Viji Samuel Thomson; Sowmya Sathyendra
Journal:  Obstet Med       Date:  2019-06-17

Review 4.  Peripartum cardiomyopathy: A systematic review of the literature.

Authors:  Zain Ul Abideen Asad; Mirwais Maiwand; Fahmi Farah; Tarun W Dasari
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

5.  Management of peripartum cardiomyopathy.

Authors:  Garrick C Stewart
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 6.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26

Review 7.  Peripartum cardiomyopathy: A puzzle closer to solution.

Authors:  James D Fett
Journal:  World J Cardiol       Date:  2014-03-26

Review 8.  Peripartum cardiomyopathy.

Authors:  Nivedita Jha; Ajay Kumar Jha
Journal:  Heart Fail Rev       Date:  2021-01-13       Impact factor: 4.214

9.  Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine.

Authors:  Piercarlo Ballo; Irene Betti; Giuseppe Mangialavori; Leandro Chiodi; Gherardo Rapisardi; Alfredo Zuppiroli
Journal:  Case Rep Med       Date:  2012-11-22

10.  Peripartum cardiomyopathy: a review.

Authors:  Michael Capriola
Journal:  Int J Womens Health       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.